PPCB — Propanc Biopharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapValue Trap

Annual balance sheet for Propanc Biopharma, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

	2022 June 30th	2023 June 30th	2024 June 30th	2025 June 30th	2026 June 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	0.004	0.01	0.021	0.012	0.832
Net Total Receivables	0.002	0.003	0.003	0.005	0.014
Prepaid Expenses
Total Other Current Assets
Total Current Assets	0.015	0.019	0.025	8.35	8.54
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.065	0.039	0.018	0.059	0.045
Other Long Term Assets
Total Assets	0.082	0.06	0.072	19.6	12.8
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	3.06	3.16	3.79	5.58	3.35
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	3.11	3.18	3.85	5.73	3.38
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	-3.02	-3.12	-3.78	13.9	9.4
Total Liabilities & Shareholders' Equity	0.082	0.06	0.072	19.6	12.8
Total Common Shares Outstanding
Total Preferred Shares Outstanding